Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Affect of revenues/BOD - Teremoto

Sorry SGE I stopped reading after the first paragraph. It is possible that you have something important to say but I just dont have the patience or desire to wade thru all the other nonsense that comprises an SGE post. No offense, if taken, then so be it.

I stopped after money in the treasury equates to a growing share price. Just not true. It should but it does not always. Why? Because if you do nothiing with the revenue and your BOD has a history of mismanaging it then the investor will not bid the price of the stock up. It is the expectations of revenue growth that moves the stock higher. Now you can ask yourself why a company that loses money has a high stock price and I am not referring to PTSC in this question? Because the investor has expectations that the company will and is moving forward. The stock market is built on results and expectations of results and continued results. Money in the bank does not move a share price higher unless an investor sees value. Just why is it that PTSC price drops when their is an obvious potential for revenue for the MMP. There are hundreds if not thousands of companies who use the technology. We banked over $100,000,000 and we dropped in share price....PTO rexam? Yes, a little. But the speculator stays away because the management is just not there.

The real bottom line issue is management or lack of. You cut, slice, dice, or pop and chop all you want....but we are at a dime because of managment.

t'moto

Share
New Message
Please login to post a reply